Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Peter Gröchenig

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Surgical Pathology|October 8, 2020
Serrated Lesions in Inflammatory Bowel Disease: Genotype-Phenotype CorrelationIva Brcic, Heather Dawson, Hans Peter Gröchenig, et al.
Gastrointestinal Endoscopy|February 25, 2018
Secondary tumors of the GI tract: origin, histology, and endoscopic findingsMagdalena M Gilg, Hans-Peter Gröchenig, Andrea Schlemmer, et al.
Zeitschrift Fur Gastroenterologie|November 9, 2023
[Use of subcutaneous Vedolizumab: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)]Simon Reider, Gottfried Novacek, Thomas Haas, et al.
Wiener Klinische Wochenschrift|September 4, 2024
Diagnosis and management of eosinophilic esophagitis and esophageal food impaction in adults : A position paper issued by the Austrian Society of Gastroenterology and Hepatology (ÖGGH)Hansjörg Schlager, Franziska Baumann-Durchschein, Karin Steidl, et al.
Wiener Klinische Wochenschrift|April 18, 2023
Management of suspected and known eosinophilic esophagitis-a nationwide survey in AustriaPhilipp Schreiner, Lorenz Balcar, Hansjörg Schlager, et al.
Wiener Klinische Wochenschrift|January 16, 2019
Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and RehabilitationAntonia Puchner, Hans Peter Gröchenig, Judith Sautner, et al.
Inflammatory Bowel Diseases|August 1, 2013
Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitisPatrizia K Kump, Hans-Peter Gröchenig, Stefan Lackner, et al.
Zeitschrift Fur Gastroenterologie|March 13, 2018
[Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases]Wolfgang Miehsler, Clemens Dejaco, Hans-Peter Gröchenig, et al.
Wiener Klinische Wochenschrift|February 5, 2019
Diagnostic delay in patients with inflammatory bowel disease in AustriaGottfried Novacek, Hans Peter Gröchenig, Thomas Haas, et al.
European Journal of Gastroenterology & Hepatology|September 10, 2019
Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel diseaseHans Peter Gröchenig, Thomas Waldhör, Thomas Haas, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Surgical Pathology|October 8, 2020
Serrated Lesions in Inflammatory Bowel Disease: Genotype-Phenotype CorrelationIva Brcic, Heather Dawson, Hans Peter Gröchenig, et al.
Gastrointestinal Endoscopy|February 25, 2018
Secondary tumors of the GI tract: origin, histology, and endoscopic findingsMagdalena M Gilg, Hans-Peter Gröchenig, Andrea Schlemmer, et al.
Zeitschrift Fur Gastroenterologie|November 9, 2023
[Use of subcutaneous Vedolizumab: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)]Simon Reider, Gottfried Novacek, Thomas Haas, et al.
Wiener Klinische Wochenschrift|September 4, 2024
Diagnosis and management of eosinophilic esophagitis and esophageal food impaction in adults : A position paper issued by the Austrian Society of Gastroenterology and Hepatology (ÖGGH)Hansjörg Schlager, Franziska Baumann-Durchschein, Karin Steidl, et al.
Wiener Klinische Wochenschrift|April 18, 2023
Management of suspected and known eosinophilic esophagitis-a nationwide survey in AustriaPhilipp Schreiner, Lorenz Balcar, Hansjörg Schlager, et al.
Wiener Klinische Wochenschrift|January 16, 2019
Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and RehabilitationAntonia Puchner, Hans Peter Gröchenig, Judith Sautner, et al.
Inflammatory Bowel Diseases|August 1, 2013
Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitisPatrizia K Kump, Hans-Peter Gröchenig, Stefan Lackner, et al.
Zeitschrift Fur Gastroenterologie|March 13, 2018
[Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases]Wolfgang Miehsler, Clemens Dejaco, Hans-Peter Gröchenig, et al.
Wiener Klinische Wochenschrift|February 5, 2019
Diagnostic delay in patients with inflammatory bowel disease in AustriaGottfried Novacek, Hans Peter Gröchenig, Thomas Haas, et al.
European Journal of Gastroenterology & Hepatology|September 10, 2019
Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel diseaseHans Peter Gröchenig, Thomas Waldhör, Thomas Haas, et al.
Pageof 2